Lataa...
A targeted genomic alteration analysis predicts survival of melanoma patients under BRAF inhibitors
Several mechanisms have been described to elucidate the emergence of resistance to MAPK inhibitors in melanoma and there is a crucial need for biomarkers to identify patients who are likely to achieve a better and long-lasting response to BRAF inhibitors therapy. In this study, we developed a target...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6422198/ https://ncbi.nlm.nih.gov/pubmed/30899440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.26707 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|